Jersey
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.65 B |
Jan. 31, 2025 | USD 24.52 | -3.88% |
|
Jersey |
The Clinical Trials company in Jersey with the highest Market Capitalization is NovoCure Limited (NasdaqGS: NVCR) at USD 2.65 B.
The Clinical Trials company in Jersey with the lowest Market Capitalization is NovoCure Limited (NasdaqGS: NVCR) at USD 2.65 B.
The top 10 Clinical Trials companies in Jersey by Market Capitalization are and NovoCure Limited.
The bottom 10 Clinical Trials companies in Jersey by Market Capitalization are and NovoCure Limited.